Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Canaccord Genuity 39th Annual Growth Conference
Thursday, August 8, 2019
1:00pm EDT